MedDataX Logo

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

NCT05509166 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-07-28

No results posted yet for this study

Summary

The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.

Conditions

  • Heavy Drinking
  • Mental Health Issue

Interventions

BEHAVIORAL

LGBTQ-affirmative Cognitive Behavioral Therapy

10-session LGBTQ-affirmative psychotherapy using CBT techniques

BEHAVIORAL

LGBTQ-affirmative Treatment-As-Usual

10-session LGBTQ-affirmative psychotherapy

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • John E Pachankis, PhD · Yale University

  • Tonda Hughes, PhD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2027-02-01
Completion
2027-08-01

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509166 on ClinicalTrials.gov